New Zealand markets closed

MRNA Jan 2024 130.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
3.8000+0.7000 (+22.58%)
As of 03:10PM EDT. Market open.
Full screen
Previous close3.1000
Expiry date2024-01-19
Day's range3.3500 - 3.8500
Contract rangeN/A
Open interest1.65k
  • Motley Fool

    If I Could Only Buy 3 Stocks in 2023, I'd Pick These

    CRISPR Therapeutics (NASDAQ: CRSP) specializes in gene editing, or the repair of faulty genes responsible for disease. Right now, CRISPR is heading for its biggest moment ever -- a regulatory decision on what may become its first commercialized product. The U.S. Food and Drug Administration (FDA) is set to decide on exa-cel for sickle cell disease in December and on exa-cel for beta thalassemia in March.

  • Zacks

    Is it Time to Buy Pfizer, Moderna, or AstraZeneca's Stock?

    Despite slowing COVID-19 vaccine sales these healthcare titans are trading at more reasonable valuations with a lot of the risk-to-reward being priced into their stocks considering their earnings potential.

  • Zacks

    Moderna (MRNA) Outpaces Stock Market Gains: What You Should Know

    In the latest trading session, Moderna (MRNA) closed at $100.27, marking a +0.83% move from the previous day.